Thymogen
Adults · Russian Cytomed IM product · Adjunctive treatment indications
Thymogen contains alpha-glutamyl-tryptophan. This reference covers the adult intramuscular regimen in the Russian product leaflet. Adults · Russian Cytomed IM product · Adjunctive treatment indications.
Reviewed 2026-10-17. A source reference, not a personal treatment plan. Discuss treatment decisions with a qualified clinician.
Dose reference
| LABEL CONTEXT | Dose | Frequency | Context |
|---|---|---|---|
| Adult IM label | 100 mcg | Once daily · 3–10 days | Source |
| Specified skin infections | 100 mcg | Once daily · 7 days | Selected purulent-inflammatory skin and soft-tissue indications in the adult label. Source |
This refers to the Russian 100 mcg/mL medicinal product. It is not a SubQ longevity protocol or a label for the separate intranasal product. Product authorisation in Russia does not imply authorisation in other countries.
Source context
The manufacturer’s leaflet names adjunctive treatment of specified illnesses associated with reduced immunity. It lists 100 mcg once daily by intramuscular injection in adults, with duration depending on the indication.
Reading the dose correctly
This refers to the Russian 100 mcg/mL medicinal product. It is not a SubQ longevity protocol or a label for the separate intranasal product. Product authorisation in Russia does not imply authorisation in other countries.
Download the chart
Further reading
Thymogen monograph on myPeptides
References
Does the reference apply to other formulations?
Only the product, preparation and route named here are covered. A shared substance name does not establish an equivalent amount for another formulation.
Where can I read the wider evidence?
The linked myPeptides Thymogen monograph covers the mechanism, human and preclinical evidence, and important distinctions between related substances.